A detailed history of Resources Management Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Resources Management Corp holds 1,463 shares of MRNA stock, worth $92,403. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,463
Previous 1,518 3.62%
Holding current value
$92,403
Previous $162,000 7.41%
% of portfolio
0.03%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $5,566 - $9,163
-55 Reduced 3.62%
1,463 $174,000
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $341 - $461
4 Added 0.26%
1,518 $162,000
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $98,356 - $147,768
1,415 Added 1429.29%
1,514 $151,000
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $109,617 - $164,686
-1,577 Reduced 94.09%
99 $151,000
Q3 2023

Nov 16, 2023

BUY
$96.41 - $126.61 $4,338 - $5,697
45 Added 2.76%
1,676 $173,000
Q2 2023

Aug 16, 2023

SELL
$118.5 - $160.53 $1.07 Million - $1.46 Million
-9,069 Reduced 84.76%
1,631 $198,000
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $1.28 Million - $1.85 Million
9,410 Added 729.46%
10,700 $380,000
Q4 2022

Feb 08, 2023

BUY
$118.38 - $210.04 $4,735 - $8,401
40 Added 3.2%
1,290 $232,000
Q3 2022

Nov 15, 2022

BUY
$118.07 - $194.18 $4,132 - $6,796
35 Added 2.88%
1,250 $148,000
Q2 2022

Aug 10, 2022

BUY
$117.13 - $176.59 $13,704 - $20,661
117 Added 10.66%
1,215 $174,000
Q1 2022

May 20, 2022

BUY
$126.46 - $235.05 $15,301 - $28,441
121 Added 12.38%
1,098 $189,000
Q4 2021

Feb 04, 2022

BUY
$225.82 - $368.51 $201,205 - $328,342
891 Added 1036.05%
977 $248,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $2,440 - $5,329
11 Added 14.67%
86 $33,000
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $4,930 - $12,739
-75 Reduced 50.0%
75 $8,000
Q3 2020

Nov 12, 2020

BUY
$54.34 - $94.85 $8,151 - $14,227
150 New
150 $11,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $24.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Resources Management Corp Portfolio

Follow Resources Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Resources Management Corp with notifications on news.